Metformin treatment in diabetes and heart failure: When academic equipoise meets clinical reality

Trials

Volumn 10, Issue , 2009, Pages

  Eurich, Dean T ^a   Tsuyuki, Ross T ^a   Majumdar, Sumit R ^a   McAlister, Finlay A ^a   Lewanczuk, Richard ^a   Shibata, Marcelo C ^a   Johnson, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLITAZONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; PLACEBO; SULFONYLUREA; ANTIDIABETIC AGENT;

AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEART FAILURE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; CANADA; DRUG LABELING; PATIENT SELECTION; PILOT STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALBERTA; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG LABELING; FEASIBILITY STUDIES; FEMALE; HEART FAILURE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PATIENT SELECTION; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 61349138261     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-12     Document Type: Article

References (43)

1. DeFronzo RA Goodman AM Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group N Engl J Med 1995, 333:541-549. 10.1056/NEJM199508313330902 7623902
2. Johnson JA Majumdar SR Simpson SH Toth EL Decreased mortality associated with metformin use compared to sulfonylurea monotherapy in type 2 diabetes mellitus Diabetes Care 2002, 25:2244-2248. 10.2337/ diacare.25.12.2244 12453968
3. UK Prospective Diabetes Study group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 1998, 352:854-865. 10.1016/ S0140-6736(98)07037-8 9742977
4. Eurich DT Majumdar SR McAlister FA Tsuyuki RT Johnson JA Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure Diabetes Care 2005, 28:2345-2351. 10.2337/ diacare.28.10.2345 16186261
5. Smooke S Horwich TB Fonarow GC Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure Am Heart J 2005, 149:168-174. 10.1016/j.ahj.2004.07.005 15660049
6. Canadian Pharmaceutical Association Compendium of pharmaceuticals and specialties (Canada) 2004.
7. Inzucchi SE Metformin and heart failure: Innocent until proven guilty Diabetes Care 2005, 28:2585-2587. 10.2337/diacare.28.10.2585 16186305
8. Inzucchi SE Masoudi FA McGuire DK Metformin in heart failure Diabetes Care 2007, 30:e129. 10.2337/dc07-1686 18042738
9. Nichols GA Gullion CM Koro CE Ephross SA Brown JB The incidence of congestive heart failure in type 2 diabetes: An update Diabetes Care 2004, 27:1879-1884. 10.2337/diacare.27.8.1879 15277411
10. Kannel WB Hjortland M Castelli WP Role of diabetes in congestive heart failure: The Framingham study Am J Cardiol 1974, 34:29-34. 10.1016/ 0002-9149(74)90089-7 4835750
11. Holstein A Nahrwold D Hinze S Egberts EH Contra-indications to metformin therapy are largely disregarded Diabet Med 1999, 16:692-696. 10.1046/ j.1464-5491.1999.00115.x 10477216
12. Masoudi FA Wang Y Inzucchi SE Setaro JF Havranek EP Foody JM Krumholz HM Metformin and thiazolidinedione use in Medicare patients with heart failure JAMA 2003, 290:81-85. 10.1001/jama.290.1.81 12837715
13. Misbin RI The phantom of lactic acidosis due to metformin in patients with diabetes Diabetes Care 2004, 27:1791-1793. 10.2337/ diacare.27.7.1791 15220268
14. Stang M Wysowski DK Butler-Jones D Incidence of lactic acidosis in metformin users Diabetes Care 1999, 22:925-927. 10.2337/diacare.22.6.925 10372243
15. Fantus IG Metformin's contraindications: Needed for now Canadian Medical Association Journal 2005, 173:505-507. 1188188 16129872 10.1503/ cmaj.050401
16. Salpeter SR Greyber E Pasternak GA Salpeter EE Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis Arch Intern Med 2003, 163:2594-2602. 10.1001/archinte.163.21.2594 14638559
17. Masoudi FA Inzucchi SE Wang Y Havranek EP Foody JM Krumholz HM Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: An observational study Circulation 2005, 111:583-590. 10.1161/01.CIR.0000154542.13412.B1 15699279
18. Horlen C Malone R Bryant B Dennis B Carey T Pignone M Rothman R Frequency of inappropriate metformin prescriptions JAMA 2002, 287:2504-2505. 10.1001/jama.287.19.2504-a 12020329
19. McCormack J Johns K Tildesley H Metformin's contraindications should be contraindicated CMAJ 2005, 173:502-504. 1188187 16129871
20. Emslie-Smith AM Boyle DI Evans JM Sullivan F Morris AD Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines Diabet Med 2001, 18:483-488. 10.1046/j.1464-5491.2001.00509.x 11472468
21. Howlett HC Bailey CJ A risk-benefit assessment of metformin in type 2 diabetes mellitus Drug Saf 1999, 20:489-503. 10.2165/ 00002018-199920060-00003 10392666
22. Levenson D Patients with both diabetes and heart failure often treated with medications government considers unsafe Report on Medical Guidelines & Outcomes Research 2003, 14:1-7.
23. Rachmani R Metformin in patients with type 2 diabetes mellitus: Reconsideration of traditional contraindications European Journal of Internal Medicine 2002, 13:428-433. 10.1016/S0953-6205(02)00131-0 12384131
24. Sulkin TV Bosman D Krentz AJ Contraindications to metformin therapy in patients with NIDDM Diabetes Care 1997, 20:925-928. 10.2337/ diacare.20.6.925 9167101
25. Eurich DT McAlister FA Blackburn DF Majumdar SR Tsuyuki RT Varney J Johnson JA Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review BMJ 2007, 335:497. 1971204 17761999 10.1136/bmj.39314.620174.80
26. Sackett DL Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle CMAJ 2000, 162:1311-1314. 1232415 10813014
27. Majumdar SR Rowe BH Folk D Johnson JA Holroyd BH Morrish DW Maksymowych WP Steiner IP Harley CH Wizba BJ Hanley DA Blitz A Russell AS A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture Ann Intern Med 2004, 141:366-373. 15353428
28. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada Can J Diabetes 2003, 27:s1-s152.
29. Tsuyuki RT Fradette M Johnson JA Bungard TJ Eurich DT Ashton T Gordon W Ikuta R Komder J Mackav E Manyari D O'Reilly K Semchuk W A multicenter disease management program for hospitalized patients with heart failure J Card Fail 2004, 10:473-480. 10.1016/j.cardfail.2004.02.005 15599837
30. Johnson JA Pohar SL Secnik K Yurgin N Hirji Z Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001 BMC Health Serv Res 2006, 6:159. 1762014 17164006 10.1186/1472-6963-6-159
31. Besner HK Feemster AA Bongiorno RA Evaluation of metformin use in hospitalized patients Ashp Midyear Clinical Meeting 2004, 39:243E.
32. Khandwala HM The prevalence of contraindications to the use of metformin Can J Diabetes 2004, 28:380-384.
33. Canadian Diabetes Association Clinical Practice Guidelines Expert Committe Canadian Diabetes Association 2008 clincal practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 2008, 32(suppl 1):S1-S201.
34. Prescott RJ Counsell CE Gillespie WJ Grant AM Russell IT Kiauka S Colthart IR Ross S Shepherd SM Russell D Factors that limit the quality, number and progress of randomised controlled trials Health Technol Assess 1999, 3:1-143. 10683591
35. Taylor KM Margolese RG Soskolne CL Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer N Engl J Med 1984, 310:1363-1367. 6717508
36. Benson AB III Pregler JP Bean JA Rademaker AW Eshler B Anderson K Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study J Clin Oncol 1991, 9:2067-2075. 1941065
37. Tognoni G Alli C Avanzini F Bettelli G Colombo F Corso R Marchiolo R Zussino A Randomised clinical trials in general practice: Lessons from a failure BMJ 1991, 303:969-971. 1671349 1954424
38. Majumdar SR McAlister FA Furberg CD From knowledge to practice in chronic cardiovascular disease: A long and winding road J Am Coll Cardiol 2004, 43:1738-1742. 10.1016/j.jacc.2003.12.043 15145092
39. Nichols GA Hillier TA Erbey JR Brown JB Congestive heart failure in type 2 diabetes: Prevalence, incidence, and risk factors Diabetes Care 2001, 24:1614-1619. 10.2337/diacare.24.9.1614 11522708
40. Pocock SJ Wang D Pfeffer MA Yusuf S McMurray JJ Swedberg KB Ostergren J Michelson EL Pieper KS Granger CB Predictors of mortality and morbidity in patients with chronic heart failure Eur Heart J 2006, 27:65-75. 10.1093/eurheartj/ehi555 16219658
41. Murcia AM Hennekens CH Lamas GA Jimenez-Navarro M Rouleau JL Flaker GC Goldman S Skali H Braunwald E Pfeffer MA Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction Archives of Internal Medicine 2004, 164:2273-2279. 10.1001/ archinte.164.20.2273 15534166
42. Laupacis A Mamdani M Observational studies of treatment effectiveness: some cautions Ann Intern Med 2004, 140:923-924. 15172907
43. D'Agostino RB Jr D'Agostino RB Sr Estimating treatment effects using observational data JAMA 2007, 297:314-316. 10.1001/jama.297.3.314 17227985